Inflammatory Gene Polymorphisms and Ischaemic Heart Disease: Review of Population Association Studies

Overview

Journal Heart

Date 2002 Jan 18

PMID 11796541

Citations 43

Authors

F Andreotti

I Porto

F Crea

A Maseri

Affiliations

Soon will be listed here.

Abstract

Inflammation and genetics are both prominent mechanisms in the pathogenesis of atherosclerosis and arterial thrombosis. Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1. Although they are very preliminary and partly conflicting, the data provide some evidence that alterations in the genetics of the inflammatory system may modify the risk of ischaemic heart disease.

Citing Articles

Evidence Accumulates: Patients with Ascending Aneurysms Are Strongly Protected from Atherosclerotic Disease.

Waldron C, Zafar M, Ziganshin B, Weininger G, Grewal N, Elefteriades J Int J Mol Sci. 2023; 24(21).

PMID: 37958625 PMC: 10650782. DOI: 10.3390/ijms242115640.

Bioinformatics and System Biological Approaches for the Identification of Genetic Risk Factors in the Progression of Cardiovascular Disease.

Barua J, Omit S, Rana H, Podder N, Chowdhury U, Rahman M Cardiovasc Ther. 2022; 2022:9034996.

PMID: 36035865 PMC: 9381297. DOI: 10.1155/2022/9034996.

Association of the PECAM-1 (Leu125Val) and P-Selectin (Thr715Pro) Gene Polymorphisms With Unexplained Spontaneous Miscarriages.

Vlachadis N, Tsamadias V, Siori M, Vrachnis N, Economou E Cureus. 2022; 14(2):e21859.

PMID: 35273840 PMC: 8901090. DOI: 10.7759/cureus.21859.

Inflammation and cardiovascular disease: From mechanisms to therapeutics.

Alfaddagh A, Martin S, Leucker T, Michos E, Blaha M, Lowenstein C Am J Prev Cardiol. 2021; 4:100130.

PMID: 34327481 PMC: 8315628. DOI: 10.1016/j.ajpc.2020.100130.

Association between IL-1β + 3954C/T polymorphism and myocardial infarction risk: A meta-analysis.

Fang Y, Xie H, Lin Z Medicine (Baltimore). 2018; 97(30):e11645.

PMID: 30045312 PMC: 6078675. DOI: 10.1097/MD.0000000000011645.

References

Braun J, Marz W, Winkelmann B, Donner H, Henning Usadel K, Badenhoop K . Tumour necrosis factor beta alleles and hyperinsulinaemia in coronary artery disease. Eur J Clin Invest. 1998; 28(7):538-42. DOI: 10.1046/j.1365-2362.1998.00334.x. View

Schmalzing D, Belenky A, Novotny M, Koutny L, Adourian A, Matsudaira P . Microchip electrophoresis: a method for high-speed SNP detection. Nucleic Acids Res. 2000; 28(9):E43. PMC: 103316. DOI: 10.1093/nar/28.9.e43. View

Samani N . Molecular genetics of coronary artery disease: measuring the phenotype. Clin Sci (Lond). 1998; 95(6):645-6. View

Syrris P, Carter N, Metcalfe J, Kemp P, Grainger D, Kaski J . Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond). 1998; 95(6):659-67. DOI: 10.1042/cs0950659. View

Wang X, Sim A, Wilcken D . A common polymorphism of the transforming growth factor-beta1 gene and coronary artery disease. Clin Sci (Lond). 1998; 95(6):745-6. View

Ross R . Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340(2):115-26. DOI: 10.1056/NEJM199901143400207. View

Ye S, Usher D, Virgil D, Zhang L, Yochim S, Gupta R . A PstI polymorphism detects the mutation of serine128 to arginine in CD 62E gene - a risk factor for coronary artery disease. J Biomed Sci. 1999; 6(1):18-21. DOI: 10.1007/BF02256419. View

Francis S, Camp N, Dewberry R, Gunn J, Syrris P, Carter N . Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation. 1999; 99(7):861-6. DOI: 10.1161/01.cir.99.7.861. View

Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W . A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol. 1999; 19(4):932-8. DOI: 10.1161/01.atv.19.4.932. View

10.

Hubacek J, Rothe G, Pitha J, Skodova Z, Stanek V, Poledne R . C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 1999; 99(25):3218-20. DOI: 10.1161/01.cir.99.25.3218. View

11.

Serebruany V, Murugesan S, Pothula A, Semaan H, Gurbel P . Soluble PECAM-1, but not P-selectin, nor osteonectin identify acute myocardial infarction in patients presenting with chest pain. Cardiology. 1999; 91(1):50-5. DOI: 10.1159/000006876. View

12.

Wenzel K, Stahn R, Speer A, Denner K, Glaser C, Affeldt M . Functional characterization of atherosclerosis-associated Ser128Arg and Leu554Phe E-selectin mutations. Biol Chem. 1999; 380(6):661-7. DOI: 10.1515/BC.1999.082. View

13.

Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P . Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation. 1999; 100(8):793-8. DOI: 10.1161/01.cir.100.8.793. View

14.

Wenzel K, Baumann G, Felix S . The homozygous combination of Leu125Val and Ser563Asn polymorphisms in the PECAM1 (CD31) gene is associated with early severe coronary heart disease. Hum Mutat. 1999; 14(6):545. DOI: 10.1002/(SICI)1098-1004(199912)14:6<545::AID-HUMU20>3.0.CO;2-5. View

15.

Manzoli A, Andreotti F, Varlotta C, Mollichelli N, Verde M, van de Greef W . Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease. Cardiologia. 1999; 44(9):825-30. View

16.

Azzawi M, Hasleton P . Tumour necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease. Cardiovasc Res. 2000; 43(4):850-9. DOI: 10.1016/s0008-6363(99)00138-8. View

17.

Blobe G, Schiemann W, Lodish H . Role of transforming growth factor beta in human disease. N Engl J Med. 2000; 342(18):1350-8. DOI: 10.1056/NEJM200005043421807. View

18.

Gardemann A, Knapp A, Katz N, Tillmanns H, Haberbosch W . No evidence for the CD31 C/G gene polymorphism as an independent risk factor of coronary heart disease. Thromb Haemost. 2000; 83(4):629. View

19.

Iacoviello L, Donati M, Gattone M . Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel disease and myocardial infarction. Circulation. 2000; 101(18):E193. DOI: 10.1161/01.cir.101.18.e193. View

20.

Yokota M, Ichihara S, Lin T, Nakashima N, Yamada Y . Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation. 2000; 101(24):2783-7. DOI: 10.1161/01.cir.101.24.2783. View